HONG KONG, SHENZHEN, China, and Montpellier, France, April 4, 2019 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading cross-border life science investment group, announced today that it has entered into…

BioCentury – Dec 8, 2018 Despite global trade headwinds and a choppy market for biopharma stocks in China, WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) successfully price its Hong Kong listing…

LONDON and WALTHAM, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) today announced that the Companies have entered into a definitive agreement pursuant to which GSK will acquire…

September 18, 2018, Bloomberg Report WuXi AppTec Co., the Chinese contract medical researcher, has submitted an application for a Hong Kong share sale, according to people with knowledge of the…

  Money is rushing into biotech at breakneck speed this year, and one part of the globe is accounting for much of the uptick: China. VC deals were teeming with…

Deal Street Asia / Jul 5, 2018 China Investment Corporation (CIC), a sovereign wealth fund has participated in a RMB1 billion (US$151 million) series D round in Beijing-based oncology, big data…

SHANGHAI, June 29, 2018 /PRNewswire/ — I-Mab Biopharma, a company focusing on innovative Biologics in therapeutic areas of immuno-oncology and immuno-inflammation, announced the completion of Series C financing for USD…

HONG KONG and MONTPELLIER, France, June 3, 2018 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading cross-border life science investment group, has completed a Series A investment, as the first…

MENLO PARK, Calif. & HONG KONG–(BUSINESS WIRE) — GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced it has raised…

CHINESE INVESTORS ARE LOOKING TO EUROPE FOR INNOVATION AT ATTRACTIVE PRICES BY STEPHEN HANSEN, ASSOCIATE EDITOR The historically underfunded European biotech sector is in the early stages of tapping into…